Shawn Cross - Net Worth and Insider Trading
Shawn Cross Net Worth
The estimated net worth of Shawn Cross is at least $143,466 dollars as of 2024-11-08. Shawn Cross is the CEO & Chair of the Board of Applied Molecular Transport Inc and owns about 545,499 shares of Applied Molecular Transport Inc (AMTI) stock worth over $143,466. Details can be seen in Shawn Cross's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shawn Cross has not made any transactions after 2023-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shawn Cross
Shawn Cross Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shawn Cross owns 3 companies in total, including Applied Molecular Transport Inc (AMTI) , GT Biopharma Inc (GTBP) , and BioPlus Acquisition Corp (BIOS) .
Click here to see the complete history of Shawn Cross’s form 4 insider trades.
Insider Ownership Summary of Shawn Cross
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AMTI | Applied Molecular Transport Inc | 2023-11-22 | Chief Financial Officer |
GTBP | GT Biopharma Inc | 2017-11-16 | director & Chief Executive Officer |
BIOS | BioPlus Acquisition Corp | 2021-12-02 | director |
Shawn Cross Latest Holdings Summary
Shawn Cross currently owns a total of 1 stock. Shawn Cross owns 545,499 shares of Applied Molecular Transport Inc (AMTI) as of November 22, 2023, with a value of $143,466.
Latest Holdings of Shawn Cross
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AMTI | Applied Molecular Transport Inc | 2023-11-22 | 545,499 | 0.26 | 143,466 |
Holding Weightings of Shawn Cross
Shawn Cross Form 4 Trading Tracker
According to the SEC Form 4 filings, Shawn Cross has made a total of 8 transactions in Applied Molecular Transport Inc (AMTI) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Applied Molecular Transport Inc is the sale of 110,802 shares on November 22, 2023, which brought Shawn Cross around $17,728.
Insider Trading History of Shawn Cross
- 1
Shawn Cross Trading Performance
Shawn Cross Ownership Network
Ownership Network List of Shawn Cross
Ownership Network Relation of Shawn Cross
Shawn Cross Owned Company Details
What does Applied Molecular Transport Inc do?
Who are the key executives at Applied Molecular Transport Inc?
Shawn Cross is the Chief Financial Officer of Applied Molecular Transport Inc. Other key executives at Applied Molecular Transport Inc include director & Chief Executive Officer Mahmood Tahir Ph.d. , VP & Finance & Bus. Ops. Brandon Hants , and Chief Technical Officer Douglas A. Rich .
Applied Molecular Transport Inc (AMTI) Insider Trades Summary
Over the past 18 months, Shawn Cross made 4 insider transaction in Applied Molecular Transport Inc (AMTI) with a net sale of 400,768. Other recent insider transactions involving Applied Molecular Transport Inc (AMTI) include a net sale of 222,101 shares made by Brandon Hants , a net sale of 474,999 shares made by Mahmood Tahir Ph.d. ,
In summary, during the past 3 months, insiders sold 0 shares of Applied Molecular Transport Inc (AMTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,097,868 shares of Applied Molecular Transport Inc (AMTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,097,868 shares.
Applied Molecular Transport Inc (AMTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Applied Molecular Transport Inc Insider Transactions
Shawn Cross Mailing Address
Above is the net worth, insider trading, and ownership report for Shawn Cross. You might contact Shawn Cross via mailing address: 1825 K Street Suite 510, Washington Dc 20006.